These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27473713)

  • 1. Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand.
    Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
    Int J Clin Pharm; 2016 Oct; 38(5):1269-76. PubMed ID: 27473713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients.
    Phueanpinit P; Pongwecharak J; Sumanont S; Krska J; Jarernsiripornkul N
    J Eval Clin Pract; 2017 Dec; 23(6):1387-1394. PubMed ID: 28809071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand.
    Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
    Prim Health Care Res Dev; 2018 Nov; 19(6):598-604. PubMed ID: 29551098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand.
    Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
    Expert Opin Drug Saf; 2016; 15(4):417-26. PubMed ID: 26742855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study.
    Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
    Int J Pharm Pract; 2019 Aug; 27(4):362-369. PubMed ID: 30912610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.
    Phueanpinit P; Jarernsiripornkul N; Pongwecharak J; Krska J
    Int J Clin Pharm; 2014 Dec; 36(6):1205-12. PubMed ID: 25288144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription pattern of NSAIDs and the prevalence of NSAID-induced gastrointestinal risk factors of orthopaedic patients in clinical practice in Korea.
    Lee SH; Han CD; Yang IH; Ha CW
    J Korean Med Sci; 2011 Apr; 26(4):561-7. PubMed ID: 21468265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk perception of NSAIDs in hospitalized patients in Greece.
    Karakitsiou M; Varga Z; Kriska M; Kristova V
    Bratisl Lek Listy; 2017; 118(7):427-430. PubMed ID: 28766354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study.
    Koffeman AR; Valkhoff VE; Celik S; W't Jong G; Sturkenboom MC; Bindels PJ; van der Lei J; Luijsterburg PA; Bierma-Zeinstra SM
    Br J Gen Pract; 2014 Apr; 64(621):e191-8. PubMed ID: 24686883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis.
    Belshaw Z; Asher L; Dean RS
    Prev Vet Med; 2016 Sep; 131():121-126. PubMed ID: 27544261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study.
    Erdeljic V; Francetic I; Macolic Sarinic V; Bilusic M; Makar Ausperger K; Huic M; Mercep I
    Pharm World Sci; 2006 Oct; 28(5):318-25. PubMed ID: 17111239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal symptoms in NSAID users in an 'average risk population': results of a large population-based study in randomly selected Dutch inhabitants.
    Tielemans MM; van Rossum LG; Eikendal T; Focks JJ; Laheij RJ; Jansen JB; van Oijen MG
    Int J Clin Pract; 2014 Apr; 68(4):512-9. PubMed ID: 24499203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
    Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
    Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prescribing patterns of nonsteroidal anti-inflammatory agents in a tertiary setting.
    Khalil V; Wang W; Charlson L; Blackley S
    Int J Evid Based Healthc; 2019 Sep; 17(3):164-172. PubMed ID: 31211729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do patients in rheumatologic care know about the risks of NSAIDs?
    Ornbjerg LM; Andersen HB; Kryger P; Cleal B; Hetland ML
    J Clin Rheumatol; 2008 Apr; 14(2):69-73. PubMed ID: 18391673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
    Scheiman JM; Hindley CE
    Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
    Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS
    Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.